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A ‘‘systematic review attempts to collate all empirical
evidence that meets prespecified eligibility criteria to
answer a specific research question’’ [1]. To achieve this
objective, the current paradigm is to conduct searches in
several electronic databases and other literature sources.
The Methodological Expectations of Cochrane Intervention
Reviews (MECIR) states that ‘‘searches for studies should
be as extensive as possible’’ [2], and Cochrane recommends
to search at least MEDLINE, Embase, and Cochrane Cen-
tral Register of Controlled Trials (CENTRAL), as well as
additional sources (e.g., checking reference lists, gray liter-
ature) 2e4. Methodological standards by health technology
agencies (such as NICE [5], IQWIG [6], EUnetHTA [7],
AHRQ [8]) have similar recommendations. However, it is
unlikely that even highly comprehensive search strategies
in electronic databases, as the ones conducted in Cochrane
reviews, find all the relevant evidence: Large proportions of
clinical trial results are never published and they have sys-
tematically different, typically more ‘‘negative’’ findings
than those that can be identified through extensive literature
searches [9,10]. Thorough searches in other sources (e.g.,
trial registries, conference abstracts, or regulatory reports)
might help to identify some of this hidden evidence. Yet,
relevant evidence is likely to still be systematically missed
[11].
As even the most comprehensive search strategies will
not be able to detect all relevant studies, the question re-
mains how much effort should be placed into literature
searches of electronic databases. In situations where several
trials are already found, randomly missing some would, on
average, reduce the precision of the treatment effect esti-
mates but would not systematically change the point esti-
mates or bias the results [12]. Some systematic reviews,
and especially rapid reviews, abbreviate their searches by
limiting the data sources (e.g., the number of literature da-
tabases, gray literature, contacting experts) or the specifica-
tions of the search (e.g., publication year, study type,
language). Presumably, such abbreviated searches do not
retrieve all available evidence [13e17].
Previous metaresearch (which we identified by using the
related-article function in PubMed and citation tracking of
selected key literature; not identified in a comprehensive
systematic search) aimed to determine which and how
many data sources should be searched in systematic re-
views and mainly investigated ‘‘recall’’ (sensitivity) of the
search strategies [18e21]. This is often defined as theproportion of relevant studies retrieved by the search
among the number of all relevant studies in a single data-
base, or that can be found with a ‘‘gold standard’’, for
example, by using multiple databases, searching gray liter-
ature, or using other search techniques (e.g., contacting ex-
perts working in the research field) [6,22]. Various studies
that assessed recall of different search strategies concluded
that multiple databases should be searched when doing a
systematic review [18e21]. However, studies included in
systematic reviews have varying contributions to the sum-
mary of findings [23]. It is plausible to assume that more
impactful, larger studies are published in more prestigious
journals that can be found in typical databases such as
PubMed. They are probably more prominently discussed
and cited in related research. As a consequence, such large
studies might be easier to find than smaller studies even
when simpler or abbreviated searches are used. Hence,
finding or not finding a study when using abbreviated
searches may not have such a great impact on the effect es-
timates and with that on health care decision-making. A
metric such as recall, which is just relying on the mere
number of studies found or missed, does not reflect the
impact that missed studies may (or may not) have on the
treatment effect estimates of evidence syntheses that serve
as the basis of health care decision-making.
To our knowledge, there is only one other meta-epidemi-
ological analysis of abbreviated searches that assessed this
impact on effect estimates: In a simulation study, Marshall
et al. aimed to determine the impact of a search in only
PubMed (largest component of PubMed: MEDLINE) on
more than 2,500 Cochrane reviews [24]. They found that
summary odds ratios (ORs) of binary outcomes would
not change in 71% of the reviews and that in only about
10% of the reviews, the treatment effects would differ by
more than 20% on the OR scale, which they considered a
moderate change. This study assumed that a search in
PubMed would identify all studies that are indexed in
PubMed (i.e., a 100% database recall), regardless of the
search strategy [24]. However, because of differences in
keywords, search syntax, and database structures, the effi-
ciency of search strategies often varies across data sources
[22,25]. Similarly, Hartling et al. [26], who aimed to assess
the impact of searching only a few of the databases on the
results of meta-analyses in Cochrane reviews, also used
database indexation as proxy for finding relevant studies.
Although they found that limiting the number of databases
most often did not change the results of meta-analyses [26],
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What this adds to what is known?
 Searching multiple data sources may increase the
number of studies, study participants, and observed
events contributing to meta-analyses, but abbrevi-
ated literature searches often give identical or very
similar treatment effect estimates.
 Deviations from results based on comprehensive
searches that may be relevant for clinical
decision-making may occur with any abbreviated
search approach.
What is the implication and what should change
now?
 When performing a systematic review, searching at
least two databases reduces the risk of missing in-
formation that could impact the treatment effect
estimate.
What this study adds to the existing literature?
 This study looks at the effect of abbreviated
searches on treatment effect estimates and their
precision.
a more realistic evaluation of the impact of abbreviating
searches would require the replication of searches of sys-
tematic reviews.
Our aim was to assess how treatment effect estimates of
meta-analyses of the main outcomes of a random sample of
Cochrane reviews would change if an abbreviated variant
of the comprehensive search strategy was applied.
H. Ewald et al. / Journal of Clin2. Methods
2.1. Overall methodology
Details of the rationale and design are described in the
project protocol [27]. This article emerges from a two-
part project. In the first part [28], we assessed the impact
of abbreviating literature searches on Cochrane review au-
thors’ conclusions. For that, we searched the Cochrane Li-
brary with the search terms ‘‘quality of evidence’’ OR
‘‘summary of findings’’. We randomly selected 60 Co-
chrane reviews from the fields of mental health, osteoar-
thritis, chronic respiratory diseases, cardiovascular
diseases, and cerebrovascular diseases that were published
between 2012 and 2016. The reviews had to fulfill these
eligibility criteria: (1) authors were able to draw a conclu-
sion, (2) a summary of findings table and data to reproduce
meta-analysis were present, and (3) the literature searches
in each database were conducted in 2012 or later andreported in enough detail to reproduce them. We replicated
each review’s searches for the three most frequently used
biomedical literature databases: MEDLINE (via Ovid
MEDLINE or PubMed in accordance with original search
strategy), Embase (via Embase.com), and CENTRAL (Co-
chrane Central Register of Controlled Trials via the Co-
chrane Library). These database searches as well as
reference list searching had all been conducted in the orig-
inal reviews. Replicating these searches and recombining
them resulted in 60 times 14 (i.e., 840) abbreviated
searches: MEDLINE, Embase, or CENTRAL only; MED-
LINE and Embase, MEDLINE and CENTRAL, CEN-
TRAL and Embase; MEDLINE, Embase, and
CENTRAL; and each of these combined with a search of
the included studies’ reference lists. We restricted Ovid
MEDLINE and PubMed searches to MEDLINE records on-
ly and excluded MEDLINE records from the Embase
search results to ensure a clear distinction between the
different databases and interfaces. For the reference list
searches, we first identified all eligible references from
the replicated database searches in Scopus. We then ex-
ported the reference lists to check for any references to
studies included in the original review that had not been
identified by the database searches.
We checked the original search strategies and corrected
minor errors in spelling, syntax, and operators in a few
cases before we reran the searches. As we only included
Cochrane reviews, we assumed the respective quality as-
sessments of the primary studies were well conducted.
We hence did not conduct our own formal assessments.
Risk of bias assessment of the primary studies can be found
within each of the included Cochrane reviews
(Supplementary material 2).2.2. Data selection
For this second part of the project (which is based on the
methods and data of the first part), we determined which of
the 60 Cochrane reviews reported at least one primary or
secondary outcome in the main summary of findings table
that was a binary outcome (i.e., event-based, reporting an
OR, risk ratio, or hazard ratio (Supplementary material
2). This excluded 13 reviews (references in
Supplementary material 1). If several pertinent outcomes
were reported in one review, we chose the one with the
largest number of studies contributing to it or, if there were
still several, the one mentioned first in the summary of find-
ings table (Supplementary material 2).2.3. Data extraction
From each Cochrane review, we extracted bibliographic
information and crude event data or effect estimates of the
studies combined in the selected meta-analysis. When we
conducted the 47 times 14 (i.e., 658) abbreviated searches,
we checked which of the studies that were originally
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identified by the abbreviated search at the time of the orig-
inal search.2.4. Data analysis
2.4.1. Meta-analyses based on original and abbreviated
searches
We recalculated each of the 47 original treatment effect
estimations as summary odds ratios (sORs) using the crude
event data or effect estimates of primary studies as reported
in the Cochrane reviews. For consistency, we used this re-
calculation as reference for each of the following meta-
epidemiological analyses (instead of the reported summary
effect from the summary of findings table that may be
derived with diverse meta-analytical methods). In each of
these meta-analyses, we then left out study results that
could not be found by abbreviating searches. We used
DerSimonian-Laird random-effects meta-analyses for our
main analysis and the Hartung-Knapp-Sidik-Jonkman
method and the fixed-effect approach in sensitivity analyses
[29,30]. In two reviews, no event data that we could have
meta-analyzed were reported [31,32]. Instead, we relied
on reported relative risks or hazard ratios and deemed these
as close approximations of ORs (which we found reason-
able when event rates are 10% or less [33] as in our
sample).2.4.2. Meta-epidemiological analyses
First, we quantified the loss of information that abbrevi-
ated searches caused compared with the original compre-
hensive search strategies by determining the median
number of trials, events, and participants lost per meta-
analysis. We also reported the corresponding proportions
of the number of trials, events, and participants that were
obtained compared with the comprehensive search.
Second, we assessed how often the treatment effect es-
timates (sOR) based on each abbreviated search and the
estimates based on the comprehensive search (1) were
identical (i.e., exactly the same effect estimate and confi-
dence intervals); (2) had a point estimate in the same di-
rection and the same level of statistical significance (i.e.,
both 95% confidence intervals crossed or did not cross
the null [OR 5 1]); (3) had a point estimate in the same
direction but differed in the level of statistical significance
(i.e., gain or loss of statistical significance); (4) we also
assessed how often the point estimates pointed in different
directions and had a confidence interval indicating a sta-
tistically significant effect (e.g., the original meta-
analysis indicates benefit of the experimental treatment,
but the abbreviated search leads to a meta-analysis indi-
cating harm or vice versa) and (5) how often the treatment
effect estimates could not be calculated anymore (i.e., the
abbreviated search did not retrieve any of the trialsincluded in the Cochrane review or only trials with zero
events). We deemed the situations (4) and (5) most critical
as we would expect that these have most impact on deci-
sion-making.
Third, we measured the absolute deviation of treatment
effect estimates based on the comprehensive search and
the estimates from each abbreviated search (i.e., the abso-
lute difference between the two sORs on the log-scale; re-
ported here after back transformation to the OR scale). The
estimated absolute deviation is positive by definition and
reported as x-fold deviation on the OR scale. For example,
the absolute deviation would be 1.25-fold when the esti-
mate based on a comprehensive search is an OR 5 1 and
the abbreviated search gives an OR 5 0.8 or OR 5 1.25.
Per abbreviated search, we summarized the absolute devia-
tion across all reviews by providing the median, interquar-
tile range (IQR), and range. The median absolute deviation
reflects the deviation observed in at least 50% of the re-
views, and the upper limit of the IQR reflects the deviation
in at least 75% of the reviews.
Fourth, we quantified the change of treatment effect size
that arose from abbreviated searches when compared with
the comprehensive searches and illustrated which of the
two search approaches resulted in more favorable treatment
effect estimates for the experimental treatment assessed in
each Cochrane review. We assumed that the second of the
two treatments compared in Cochrane reviews is the control
treatment (this was in 28 of the 47 reviews (60%) with pla-
cebo, usual care, or no treatment; 19 (40%) had an active
comparator). We tested any impact of the order of compar-
ators on the ratio of odds ratios (RORs) in a sensitivity anal-
ysis leaving out the reviews with active or mixed
comparisons. We coined two positive outcomes and the cor-
responding metrics so that a sOR !1 consistently indicates
more favorable effects with the experimental treatment
(e.g., a sOR for survival of 1.25 became a sOR of 0.8 for
mortality). We calculated the RORs by subtracting the
sOR based on the comprehensive search from the sOR of
the respective abbreviated search on log-scale and back
transformed them on the OR scale [34]. An ROR greater
than 1 indicates that the abbreviated search measured a
more favorable result of the treatment than the comprehen-
sive search.
Finally, we explored how the precision of the estimates
changed by calculating the ratio of standard errors per
meta-analysis. Values O 1 indicate larger standard errors
(less precision) with abbreviated searches.
We summarized the ROR and precision per abbreviated
search across all reviews by providing the mean (and stan-
dard deviation), the median (IQR), and the range. We used
the Wilcoxon signed rank test to compare the number of
events and participants across studies. P-values!0.05 were
considered statistically significant. Analyseswere performed
using Stata/IC 14.2 (StataCorp, College Station, TX, USA)
and RStudio, version 1.2.1335, (R version 3.6.1.)
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No patients were involved in this research.3. Results
The 47 original meta-analyses (Supplementary material
1) included a total of 444 randomized controlled trials
(RCTs) with data on 360,045 participants with 29,255
events (with a median of 6 trials per meta-analysis, IQR
3 to 11; median of 1,371 participants, IQR 685 to 8,041;
and median of 209 events, IQR 62 to 773). Across all trials
for which the Cochrane reviews reported crude events (432
of 444), the median event rate was 0.09 (IQR 0.04 to 0.21).
The reviews’ topics were on cardiovascular disease (21 of
47), chronic respiratory diseases (8 of 47), osteoarthritis
(7 of 47), mental health (6 of 47), and cerebrovascularTable 1. Impact of abbreviated searches on the number of trials, events, a
Cochrane reviews
Search type Trialsa





M 1 (0 to 2)
0.08 (0 to 0.2)
E 1 (0 to 2)
0.14 (0 to 0.33)
C 1 (0 to 2)
0.06 (0 to 0.2)
M þ E 0 (0 to 1)
0 (0 to 0.15)
M þ C 0 (0 to 1)
0 (0 to 0.15)
M þ R 0 (0 to 1)
0 (0 to 0.1)
E þ C 0 (0 to 1)
0.08 (0 to 0.11)
E þ R 0 (0 to 1)
0 (0 to 0.15)
C þ R 0 (0 to 1)
0 (0 to 0.13)
M þ E þ C 0 (0 to 1)
0 (0 to 0.1)
M þ E þ R 0 (0 to 1)
0 (0 to 0.06)
M þ C þ R 0 (0 to 1)
0 (0 to 0.04)
E þ C þ R 0 (0 to 0)
0 (0 to 0)
M þ E þ C þ R 0 (0 to 0)
0 (0 to 0)
Abbreviations: C, CENTRAL; E, Embase; IQR, interquartile range; no., n
a Data are reported as median (IQR).
b For two Cochrane reviews, this information was not available [31,32].disease (5 of 47). Confidence intervals were not crossing
the null in 13 of 47 meta-analyses (28%).
3.1. Loss of information
In half of all meta-analyses (median), searching only one
data source led to the loss of at least one trial; in a quarter
of the reviews, it led to the loss of at least two trials
(Table 1, Figs. 1 and 2A). With any of the abbreviated
searches, at least 86% of the trials, 98% of the events,
and 96% of the participants included in the selected
meta-analyses were still found in more than half of all
meta-analyses (highest proportion of missing information
across the 47 meta-analyses when searching Embase only:
missed 14% of trials, 2% of events, and 4% of participants).
Overall, the loss of information was highest with abbrevi-
ated searches in a single data source only (Table 1, Fig.
2AeD).nd participants included in analyses of the main binary outcomes in
Eventsa,b Participantsa







0 (32 to 0)
0 (0 to 0.09)
18 (0 to 177)
0 (0 to 0.08)
10 (0 to 59)
0.02 (0 to 0.25)
119 (0 to 417)
0.04 (0 to 0.23)
0 (0 to 38)
0 (0 to 0.1)
0 (0 to 301)
0 (0 to 0.14)
0 (0 to 18)
0 (0 to 0.05)
0 (0 to 145)
0 (0 to 0.04)
0 (0 to 13)
0 (0 to 0.03)
0 (0 to 98)
0 (0 to 0.04)
0 (0 to 9)
0 (0 to 0.03)
0 (0 to 81)
0 (0 to 0.03)
0 (0 to 6)
0 (0 to 0.02)
0 (0 to 98)
0 (0 to 0.04)
0 (0 to 20)
0 (0 to 0.06)
0 (0 to 155)
0 (0 to 0.06)
0 (0 to 6)
0 (0 to 0.04)
0 (0 to 87)
0 (0 to 0.04)
0 (to 4)
0 (0 to 0.01)
0 (0 to 68)
0 (0 to 0.03)
0 (0 to 2)
0 (0 to 0.01)
0 (0 to 45)
0 (0 to 0.02)
0 (0 to 0)
0 (0 to 0)
0 (0 to 9)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
0 (0 to 0)
umber; M, MEDLINE; R, reference list checking of included trials.
Fig. 1. Agreement of treatment effect estimates from 14 abbreviated searches with the comprehensive literature searches for each of the 47 Co-
chrane reviews. The figure shows the agreement of the treatment effect estimates resulting from a meta-analysis based on studies found with an
abbreviated search (using CENTRAL, Embase, MEDLINE, and/or reference list checking) compared with that based on all studies from the original
search. Each row corresponds to one abbreviated search; the columns each reflect one of the 47 Cochrane reviews. For many Cochrane reviews,
each search provides the same treatment effect estimates as the comprehensive search (left side). For two reviews, all searches provide point es-
timates in the opposite direction, and for one review, no search allows to calculate a treatment effect estimate (right side). Color legend: 1: full
concordance between treatment effect estimates derived from abbreviated and comprehensive searches; 2: estimates without changes in the di-
rection of the point estimate and with same statistical significance; 3: estimates with gain/loss of the statistical significance (direction of point
estimates unchanged); 4: estimates with changes in the direction of the point estimate (all were statistically nonsignificant); 5: estimates unavai-
lable. C, CENTRAL; E, Embase; M, MEDLINE; R, reference list checking of included trials. . (For interpretation of the references to color in this
figure legend, the reader is referred to the Web version of this article.)
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Treatment effect estimates based on abbreviated
searches were identical to those based on comprehensive
searches in 34% (16 of 47) to 79% (37 of 47) of the 47
meta-analyses (Figs. 1 and 3). They were not identical
but in the same direction and had the same level of statis-
tical significance in 13% (6 of 47) to 51% (24 of 47) of
the meta-analyses. They were in the same direction but
were changed in the level of significance in 2% (1 of 47)
to 6% (3 of 47) of the meta-analyses [31,35,36]. Treatment
effect estimates were in the opposite direction in 4% (2 of
47) to 9% (4 of 47) of the meta-analyses. This concerned
overall six different meta-analyses [37e42]. After con-
ducting the abbreviated searches, there were not enough
data left to estimate treatment effects in 2% (1 of 47) to
4% (2 of 47) of the meta-analyses. A total of three reviews
were thus affected [43e45]. Overall, abbreviated searches
led in 6% (3 of 47) to 13% (6 of 47) of the meta-
analyses to effects that were in the opposite direction or that
could not be estimated anymore. There was one review
where only the comprehensive search provided enough data
to conduct a meta-analysis [45].3.3. Absolute deviation and ratio of odds ratios
There was no deviation of treatment effect size estimates
at all in 50% of the meta-analyses across all abbreviated
searches (i.e., 1.00-fold deviation; exception: searchingEmbase only with 1.01-fold deviation; Table 2). The treat-
ment effect size estimates did not deviate with any abbrevi-
ated search in 75% of the reviews by more than the 1.07-
fold (upper IQR for searching Embase only, Table 2,
Fig. 4). For all abbreviated searches, there was one meta-
analysis [42], where the abbreviated search gave results
deviating substantially (absolute deviation to original
meta-analysis up to 2.39-fold; outcome: withdrawal due
to adverse events: two of the five RCTs could not be found
with any of the search strategies as they are unpublished
data from the industry sponsor and constitute 82.5% of
the weight of the meta-analysis) [42].
Treatment effect estimates of abbreviated searches were
not consistently smaller or larger than those based on
comprehensive searches: the median ROR was 1.00 (IQR
1.00 to 1.00) across all abbreviated searches, that is, there
was no change of the treatment effect size estimates in most
meta-analyses and abbreviated searches (Table 2). The
mean ROR was similar across all abbreviated searches irre-
spective of whether the searches had been based on only a
single or on multiple data sources.3.4. Precision
Using abbreviated searches introduced imprecision to a
certain extent. Standard errors were on average between
1.02- and 1.06-fold larger than with comprehensive
searches, but there were no clear differences among
Fig. 2. Loss of information due to abbreviating of searches for 47 Cochrane reviews (box plot). The figures show the loss of information resulting
from abbreviating the search strategies for each search: (A) absolute number of trials missed; (B) proportion of trials missed; (C) Proportion of pa-
tients missed; (D) Proportion of events missed. Each gray circle corresponds to one outcome from one Cochrane review. Boxes indicate the inter-
quartile range and the median across all reviews. C, CENTRAL; E, Embase; M, MEDLINE; R, reference list checking of included trials.
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Fig. 3. Concordance of treatment effect estimates from abbreviated and comprehensive literature searches in a sample of 47 Cochrane reviews.
Color legend: 1: full concordance between treatment effect estimates derived from abbreviated and comprehensive searches; 2: estimates without
changes in the direction of the point estimate and with same level of statistical significance; 3: estimates with gain/loss of the statistical signif-
icance (direction of point estimates unchanged); 4: estimates with changes in the direction of the point estimate (all were statistically nonsignif-
icant); 5: estimates unavailable. C, CENTRAL; E, Embase; M, MEDLINE; R, reference list checking of included trials. (For interpretation of the
references to color in this figure legend, the reader is referred to the Web version of this article.)
8 H. Ewald et al. / Journal of Clinical Epidemiology 128 (2020) 1e12abbreviated searches that were based on single or multiple
data sources (Table 2).3.5. Characteristics of studies that were missed by
abbreviated searches
Studies that were not found by searching only MED-
LINE were smaller and had fewer events than those that
were found (median 100 vs. 135 participants; P 5 0.003;
median 8.5 vs. 14 events; P 5 0.017). This was not the case
for Embase (median 129 vs. 127 participants; P 5 0.575;
median 16 vs. 13 events; P 5 0.685). Studies that were
not found by searching only CENTRAL were smaller (me-
dian 101 vs. 131 participants; P 5 0.026) but had similar
events (median 13 vs. 14 events; P 5 0.145).
Overall, MEDLINE retrieved three of 444 (0.7%), Em-
base six (1.4%), CENTRAL 11 (2.5%), and reference list
checking 10 (2.2%) studies that could not be found in either
of the respective other three sources.3.6. Sensitivity analyses
Results from sensitivity analyses (i.e., using the
Hartung-Knapp-Sidik-Jonkman method and the fixed-
effect approach and excluding meta-analyses without activecontrols for ROR analyses) were similar and supported the
main findings (Supplementary material 3).4. Discussion
Our analysis of 658 abbreviated searches showed that ef-
fect estimates based on abbreviated searches often came to
identical or similar statistical main results as those obtained
through comprehensive searches in Cochrane reviews.
However, in up to one in seven reviews (i.e., 6e13%),
the direction of the effect estimate changed or it was not
possible anymore to provide a result at all when relying
on abbreviated searches. This may have a substantial
impact on decision-making but which may also be an
acceptable tradeoff for users of rapid reviews [46]. Treat-
ment effect estimates of abbreviated searches were on
average not consistently smaller or larger than original es-
timates in Cochrane reviews. We could not identify an
abbreviated search that seemed to clearly outperform the
other abbreviated variants. In fact, even the most compre-
hensive of the abbreviated searches could not obtain all in-
formation that the original Cochrane search strategy
retrieved. However, abbreviated searches that were based
on at least two data sources found many more studies than
Table 2. Impact of abbreviated vs. comprehensive searches on the treatment effect estimates of meta-analyses for the main binary outcomes of 47
Cochrane reviews
Search type Absolute deviation median (IQR); range
ROR
Mean (SD); range Ratio of standard errorsMean (SD); range
Abbreviated search
M 1 (1 to 1.04); 1 to 1.83 0.98 (0.09); 0.55 to 1.13 1.02 (0.08); 0.95 to 1.52
E 1.01 (1 to 1.07); 1 to 2.39 0.99 (0.14); 0.42 to 1.42 1.06 (0.24); 0.95 to 2.59
C 1 (1 to 1.03); 1 to 1.83 1 (0.09); 0.55 to 1.23 1.02 (0.09); 0.95 to 1.52
M þ E 1 (1 to 1.02); 1 to 1.83 0.98 (0.09); 0.55 to 1.13 1.02 (0.08); 0.95 to 1.52
M þ C 1 (1 to 1.01); 1 to 1.83 1 (0.09); 0.55 to 1.23 1.02 (0.09); 0.95 to 1.52
M þ R 1 (1 to 1.01); 1 to 1.83 1 (0.08); 0.55 to 1.23 1.02 (0.09); 0.98 to 1.52
E þ C 1 (1 to 1.01); 1 to 1.83 1 (0.09); 0.55 to 1.23 1.02 (0.09); 0.95 to 1.52
E þ R 1 (1 to 1.02); 1 to 2.39 1.01 (0.12); 0.42 to 1.42 1.05 (0.24); 0.98 to 2.95
C þ R 1 (1 to 1.02); 1 to 1.83 1 (0.09); 0.55 to 1.23 1.02 (0.09); 0.98 to 1.52
M þ E þ C 1 (1 to 1); 1 to 1.83 1 (0.09); 0.55 to 1.23 1.02 (0.09); 0.95 to 1.52
M þ E þ R 1 (1 to 1); 1 to 1.83 1 (0.08); 0.55 to 1.23 1.02 (0.09); 0.98 to 1.52
M þ C þ R 1 (1 to 1); 1 to 1.83 1 (0.08); 0.55 to 1.23 1.02 (0.09); 0.98 to 1.52
E þ C þ R 1 (1 to 1); 1 to 1.83 1 (0.08); 0.55 to 1.23 1.02 (0.09); 1 to 1.52
M þ E þ C þ R 1 (1 to 1); 1 to 1.83 1 (0.08); 0.55 to 1.23 1.02 (0.09); 1 to 1.52
Abbreviations: C, CENTRAL; E, Embase; IQR, interquartile range; M, MEDLINE; R, reference list checking of included trials; ROR, ratio of odds
ratios; SD, standard deviation.
The ROR indicates the relationship of the result from the abbreviated search to the result with the comprehensive search (as ratio of odds ratios;
an ROR greater than 1 indicates that the abbreviated search measured a more favorable result of the treatment than the comprehensive search).
The absolute deviation shows the x-fold deviation on an odds ratio scale of the result with the abbreviated search from the result with the compre-
hensive search (O1 by definition). The ratio of standard errors reflects the change of precision by using abbreviated searches (values O 1 indicate
larger standard errors with abbreviated searches). For the ROR, all medians are 1 (IQR 1 to 1), with the exception of MEDLINE and Embase only
(median 1 [IQR 1 to 1.01]). For the precision, all medians are 1 (IQR 1 to 1) with the exception of M, C, ME, ER (medians 1 [IQR 1 to 1.01]), and E
(median 1 [IQR 1 to 1.03]). Hence, we here presented mean (SD).
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loss of information by including a larger number of trial
participants and events. This is in line with previous
research using technical metrics such as the recall to
compare search strategies [24]. Our results show that effect
estimates do not necessarily change when some of the theo-
retically available data are not included in an evidence
synthesis.Fig. 4. Absolute deviation of treatment effect estimates from abbreviated se
lute deviation of the treatment effect estimate resulting from a meta-analysi
Embase, MEDLINE, and/or reference list checking) compared with that bas
sulting from abbreviating the search strategies for each search. Each gray cir
tile range and the median across all reviews (the median is always 1.0 with
shown in the plot (at 2.39, indicated by ‘‘OO’’ and at 1.83, indicated by ‘‘
ence list checking of included trials.In the first part of this project [28], we analyzed the
impact of abbreviated searches on the overall conclusion
of a review. We found that abbreviated searches can be
an acceptable alternative to comprehensive searches if the
decision at hand does not require the highest possible cer-
tainty. We also found that single database searches were un-
reliable for drawing conclusions and should hence be
avoided in evidence syntheses [28]. Overall, these resultsarches for 47 Cochrane reviews (box plot). The figure shows the abso-
s based on studies found with an abbreviated search (using CENTRAL,
ed on all studies from the original search. The loss of information re-
cle corresponds to one Cochrane review. Boxes indicate the interquar-
one exception for Embase). For each search, one outlying value is not
O’’). Abbreviations: C, CENTRAL; E, Embase; M, MEDLINE; R, refer-
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abovementioned analysis by Marshall et al. [24] found that
the treatment effects would not change in most reviews
when searching only PubMed. This discrepancy may be ex-
plained by the assumptions underlying their simulation
study: instead of assuming that a search in PubMed would
identify all indexed studies, we actually tested that on a
large scale by replicating 47 searches in 14 different abbre-
viated variants.
Several limitations of our analysis merit closer attention.
First, we searched specifically in MEDLINE (not in all
sources covered by PubMed, e.g., PubMed Central) and
in the Embase-specific source of Embase.com (i.e.,
excluding MEDLINE records that are available in Embase
but are not independently indexed for Embase by the inter-
face provider Elsevier). Systematic reviewers using
PubMed may find some of the articles that our
MEDLINE-specific search did not find, and when they
would use Embase without restrictions, they probably
would find some of the MEDLINE articles. We avoided this
overlap to allow a cleaner comparison of the contributions
of each data source. Thus, we may have observed larger
disagreements between the abbreviated search variants than
what would be seen in more typical applications of PubMed
or Embase. However, this would not alter our overall
interpretation.
Second, for the reference list searches, we used Sco-
pus to make this step feasible in the several hundred
literature searches. However, although Scopus is a very
large database, not all relevant references are indexed,
and this procedure may also have resulted in an overes-
timation of the disagreement between abbreviated
searches with reference list search compared with
comprehensive searches. Again, this would not change
our overall interpretation.
Third, all of the analyses are based on binary endpoints
with focus on major clinical topics. It is possible or even
likely that any differences resulting from different search
strategies would be more pronounced in less prominent
endpoints of reviews, for example, adverse effects. Three
of the endpoints in our analysis were related to withdrawal
due to adverse events (Supplementary material 1). We have
not explored the impact on frequently underreported
continuous outcomes (such as quality of life). Outcomes
with a perceived lower relevance or research results for
more specific clinical fields may be reported more often
in lower impact journals that are less likely to be indexed
in the main literature databases. Thus, abbreviated searches
may more often generate disagreeing results for more spe-
cific topics and less prominent outcomes than our results
suggest. However, we did not assess potential predictors
of disagreeing findings.
Fourth, we did not assess the impact of databases beyond
MEDLINE, Embase, and CENTRAL, or the impact of
alternative search methods beyond reference list searching.
Cochrane reviews usually use a broad range of informationretrieval strategies, for example, searching specific context
relevant databases, searching other resources (e.g., clinical
trial registries), or contacting experts. Hence, we cannot
make inferences about abbreviated search techniques using
other data sources than MEDLINE, Embase, CENTRAL,
and reference lists.
Fifth, we only analyzed the impact of different abbrevi-
ated searches on the treatment effects from 47 Cochrane
systematic reviews. We focused on five major health topics
(mental health, osteoarthritis, chronic respiratory diseases,
cardiovascular diseases, and cerebrovascular diseases),
and our random sample may not reflect the diversity of
all systematic review topics and outcomes. Assessing a
larger sample from a wider spectrum of fields could have
provided more precise and generalizable estimates. Howev-
er, manually replicating and conducting more than the
several hundreds of searches we already conducted for
the overall project would not have been feasible.
Sixth, we included systematic reviews up to 2016 and no
more recent reviews. However, the databases considered in
this project, MEDLINE, Embase, and CENTRAL, continue
to be standard sources for systematic reviews, and there
were no fundamental changes in the typical information
retrieval processes of systematic reviews that would let us
believe that the results do not apply for more recent
situations.
Finally, we determined the impact of abbreviating
searches compared with the complex search strategies of
Cochrane reviews as gold standard, reflecting a typical
application of abbreviated searches. Because even Co-
chrane reviews may not retrieve all available evidence,
we are not able to quantify the impact of abbreviating
searches compared with theoretically perfect searches that
would identify all existing evidence.
In light of these limitations, we encourage other re-
searchers to repeat our methods, for example, in other
health fields and with more studies, to better understand
the applicability of the results. More certainty regarding
our research questions and the results would help all sys-
tematic reviewers to decide on the extent to which search-
ing is not only feasible, but also necessary to assure a
minimum certainty about the possible impact of searching
limited amounts of databases on the effect estimates.
Overall, we conclude that abbreviating literature
searches often lead to identical or very similar treatment ef-
fect estimates in systematic reviews, but relevant differ-
ences may occur occasionally. Treatment benefits or
harms found by using more comprehensive searches would
typically remain visible with abbreviated searches. Some-
times statistical significance may be gained or lost, but in
only one of seven reviews, favorable effects would seem
unfavorable (or vice versa) or all information supporting
decisions would be lost. It was not clear which type of
abbreviated searches would be preferable. More compre-
hensive searches should be considered when higher cer-
tainty is required for decision-making.
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